President of Radiological Technologies Universities, Brent D. Murphy, MS, DABR, underscores the efficacy of PET and champions increased utilization of PET in oncology.

In the linked presentation, Dr. Murphy illustrates PET advantages in both sensitivity (the probability of a positive test, given that a patient is ill) and specificity (the probability of a negative test, given that a patient is well). The improvements discussed can apply to small-animal PET and preclinical scans, like the Trans-PET® BioCaliburn®.

Download PDF